Skip to main content
Clinical Trials/NCT05409209
NCT05409209
Active, not recruiting
Not Applicable

Carotid Plaque Length to Predict Cardiovascular Events

Changhai Hospital5 sites in 1 country5,000 target enrollmentJanuary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Changhai Hospital
Enrollment
5000
Locations
5
Primary Endpoint
major cardiovascular event
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 5000 patients for suspected CAD who referred to coronary angiography from January 2017 through December 2018.

Detailed Description

Patients with coronary artery disease who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was performed before coronary angiography, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
December 31, 2030
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pan Li

Clinical Professor

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.

Exclusion Criteria

  • Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.

Outcomes

Primary Outcomes

major cardiovascular event

Time Frame: 3 years

A composite of cardiovascular death, myocardial infarction, and ischemic stroke

Secondary Outcomes

  • ischemic stroke(3 years)
  • myocardial infarction(3 years)
  • major vascular event(3 years)
  • all-cause death(3 years)
  • cardiovascular death(3 years)
  • coronary artery revascularization(3 years)

Study Sites (5)

Loading locations...

Similar Trials